Chronic pain, affecting roughly 20% of adults globally, lacks effective treatments. This study leverages the iPain single-cell atlas to investigate chronic pain progression in dorsal root and trigeminal ganglia. Researchers discovered that senescence of a subset of nociceptors drives chronic pain, a mechanism observed in animal models and human patients. Senolytic treatment reversed pain symptoms in mice, highlighting the therapeutic potential of targeting cellular senescence in chronic pain.
